MRNA

MRNA AI+
Edward 12-21 US Equity Public

MRNA

Rate this post:
0
Kommentarer (1)
AI+ Standard 12-21
Dette svar blev genereret af AI. Selvom vi stræber efter nøjagtighed, kan det indeholde fejl.

Moderna (MRNA) presents an interesting profile when examining various Fintel data points, particularly concerning institutional sentiment and market microstructure.

Institutional Ownership Trends

Institutional ownership in Moderna remains substantial, with 1257 institutions holding a total of 296,202,081 shares, representing 76.13% of the outstanding shares (excluding 13D/G filings).1 However, there has been a slight decrease in institutional shares held (-0.79%) and a more notable reduction in the number of institutional owners (-7.62%) in the most recent quarter.1 Major holders include Vanguard Group Inc, BlackRock, Inc., and Baillie Gifford & Co.1 This mixed signal suggests some re-evaluation by institutional investors, which can be further explored through Fintel's Fund Sentiment Score.1

Short Interest and Market Speculation

Moderna currently shows a significant level of short interest. Approximately 66.24 million shares are shorted, which accounts for 18.23% of the float.2 The Days to Cover ratio stands at 6.90, indicating that it would take nearly seven trading days for short sellers to cover their positions, which could amplify price movements during periods of high demand.2 Furthermore, the off-exchange short volume ratio is notably high at 55.67%, suggesting considerable shorting activity occurring outside of traditional exchanges.2

Options Market Activity

The options market for MRNA offers additional insights into speculative sentiment. Fintel provides tools to track real-time options flow, unusual trades, and gamma exposure, which can reveal significant bullish or bearish positioning by sophisticated traders.1 Analyzing the put/call open interest ratio can help gauge the overall sentiment of actively managed funds, as passively managed funds typically do not engage in options trading.1

Recent Performance Context

It's worth noting that MRNA's stock price experienced a significant decline over the past year, dropping by 67.55% from $82.30 on August 6, 2024, to $26.71 on August 6, 2025.1 This historical context is crucial when evaluating current institutional and short interest positions.

Rate this response:
0

Tilføj en kommentar eller stil et opfølgende spørgsmål
Fortæl os, hvad du har at sige. Du kan inkludere links, men ikke *bare* links. Del dine tankevækkende meninger. Brug Markdown .
Using Standard
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista